Authors


Richelle L. Guerrero-Wooley, MD

Latest:

COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings

This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.



Rajeev Shah, PharmD, AAHIVP, BCIDP

Latest:

Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.


Bo Ram Keum, PharmD candidate

Latest:

Safety of Cefazolin Has Been Underestimated for GBS Prophylaxis During Labor

Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).



Renata O. Smith, PharmD, AAHIVP

Latest:

Gender-Affirming Care in Persons Living With HIV

Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.


Kari A. Mergenhagen, PHARMD, BCPS, BCIDP

Latest:

Outpatient Antimicrobial Stewardship: The Keys to Developing a Successful Program

This form of stewardship can reduce unnecessary antibiotic prescribing, reduce costs, and optimize patient outcomes.


Shane J. Softy

Latest:

Pharmacotherapy Options for COVID-19: Does Fluvoxamine Have a Place in Therapy?

The need for safe and effective treatment against the various strains of COVID-19 increase, and investigators continue to assess various pharmacologic options.


Tori Whitacre Martonicz

Latest:

AI in HAI Prevention: A Sustainable Approach

Hospitals grapple with the costly burden of healthcare-associated infections (HAIs), and artificial intelligence (AI) is emerging as a game-changer in revolutionizing infection prevention strategies.


Jonathan H. Ryder, MD

Latest:

Updates and Controversies in Necrotizing Soft Tissue Infections

Changes in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.


Armand Butera

Latest:

CDC Influenza Surveillance Weekly Report

Clinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.


Tiana Patriarca, PharmD candidate

Latest:

Linezolid Coadministration With Medications for Opioid Use Disorder: A Serotonin Toxicity Tightrope?

This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.


Thein Myint, MBBS

Latest:

Sorry Ganciclovir, You’re Just Not the One for Me

Important clinical considerations to know about resistant CMV infections.


Laura L. Bio, PharmD, BCPS, BCIDP

Latest:

The Role of Pharmacists in the World of Pediatric Antimicrobial Stewardship

The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.


Jillian Walters, PharmD, MPH

Latest:

The ART of Implementing an Antiretroviral Stewardship Program

By addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.


Rakhshanda Akram, MD

Latest:

What's in the Pipeline?

A look at up-and-coming HIV drugs in development.



SHELLEY HANKINS, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


Dava Stewart

Latest:

Using Deep Sequencing Technology to Detect HCV Resistant Variants

A research team from the Netherlands turns to deep sequencing technology to detect hepatitis C virus resistant variants.



Contagion&reg Editorial Staff

Latest:

The ID Pipeline: Drug Development Debrief | Week of September 13, 2020

A quick debrief of the week’s top FDA approvals, FDA authorizations, or other infectious disease pipeline developments from the past week.


Jose A. Vazquez, MD

Latest:

Medical Importance of Microbial Biofilms in the Management of Infectious Diseases

Biofilms are an emerging clinical problem despite the fact that most clinicians don’t even think of biofilms when managing infections.


Brandon May

Latest:

MSM Who Use Mobile Apps for Sex More Likely to Have STIs

Men who have sex with men who seek out sexual partners online are more likely to report sexually transmitted infections, including syphilis, gonorrhea, and chlamydia.


Debra Goff, PharmD, FCCP

Latest:

Globalization of Antibiotic Stewardship Programs: The World Is Waiting

The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.


Amanda Binkley, PharmD, AAHIVP

Latest:

Treatment as Prevention: A Comprehensive Approach to Hepatitis C Virus in Persons Who Inject Drugs

With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.


Daniela Dimarco, MD

Latest:

Optimal Vancomycin Dosing in Obese Patients: Moving Toward the AUC

This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.



Ilia Rochlin, PhD

Latest:

Tick, Tick, Tick: Vector-Borne Diseases Ramp Up

Infections transmitted by these bloodsucking species are on the rise worldwide.



Amesh A. Adalja, MD, FIDSA

Latest:

Will Pennsylvania Proposal Sanction Improper Treatment of Lyme Disease?

Amesh A. Adalja, MD, FIDSA argues that a bill being considered in the Pennsylvania state legislature will ultimately result in increased antibiotic resistance and will set back the clock for finding appropriate treatments for Lyme disease.

© 2024 MJH Life Sciences

All rights reserved.